Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 4/20 | 0.35 |
| ▸ | PTGES | O14684 | 1/20 | 0.35 |
| ▸ | RXRB | P28702 | 3/20 | 0.34 |
| ▸ | RXRA | P19793 | 2/20 | 0.34 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.34 |
| ▸ | TUBB | P07437 | 1/20 | 0.34 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.34 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.34 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.34 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.34 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.34 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.34 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.34 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.34 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.34 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.34 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21944404 | 0.88 | TUBB4A (0.34) | KDM4EL3MBTL1ATMPPARGTUBB4A | |
| SCHEMBL9890899 | 0.84 | PPARG (0.39) | KDM4EL3MBTL1ATMPPARGPTGES | |
| SCHEMBL10130216 | 0.83 | ESR1 (0.43) | KDM4EL3MBTL1ATMTUBB4ATUBB | |
| SCHEMBL31450454 | 0.83 | ESR1 (0.43) | KDM4EL3MBTL1ATMTUBB4ATUBB | |
| SCHEMBL29517009 | 0.83 | ESR1 (0.43) | KDM4EL3MBTL1ATMTUBB4ATUBB | |
| SCHEMBL11981041 | 0.83 | KDM4E (0.46) | KDM4EL3MBTL1ATMTUBB4ATUBB | |
| SCHEMBL15480403 | 0.83 | KDM4E (0.46) | KDM4EL3MBTL1ATMTUBB4ATUBB | |
| SCHEMBL30475208 | 0.83 | KDM4E (0.46) | KDM4EL3MBTL1ATMTUBB4ATUBB | |
| SCHEMBL25777639 | 0.83 | KDM4E (0.41) | KDM4EL3MBTL1ATMPPARGPTGES | |
| SCHEMBL24601329 | 0.83 | KDM4E (0.33) | KDM4EL3MBTL1ATMPPARGRXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11793074-B2 | Organic compound and photoelectric conversion element | CANON KABUSHIKI KAISHA (JP) | 2023-10-17 | — | — | US | disclosed |
| US-11793074-B2 | Organic compound and photoelectric conversion element | CANON KABUSHIKI KAISHA (JP) | 2023-10-17 | — | — | US | disclosed |
| US-20210057653-A1 | ORGANIC COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT | CANON KK (JP) | 2021-02-25 | — | — | US | disclosed |
| US-10868260-B2 | Organic compound and photoelectric conversion element | CANON KABUSHIKI KAISHA (JP) | 2020-12-15 | — | — | US | disclosed |
| US-20190088885-A1 | ORGANIC COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2019-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11793074-B2 | Organic compound and photoelectric conversion element | CRY1, CYP1A1, CCNE2 | KDM4E 1730/4885L3MBTL1 1860/4885ATM 2983/4885 |
| US-20210057653-A1 | ORGANIC COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT | CRY1, CYP1A1, CCNE2 | KDM4E 1730/4885L3MBTL1 1860/4885ATM 2983/4885 |
| US-10868260-B2 | Organic compound and photoelectric conversion element | CRY1, CYP1A1, CCNE2 | KDM4E 1730/4885L3MBTL1 1860/4885ATM 2983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.